Skip to content

Vericel

US · VCEL #2759 by market cap Listed 1970
57.52 -0.74 -1.27%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Rating change
    TD Cowen Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $58
    Market Newswire · 2026/7/31
  • Rating change
    Truist Financial Maintains Vericel(VCEL.US) With Buy Rating, Announces Target Price $54
    Market Newswire · 2026/7/16
  • Rating change
    Truist Financial Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $58
    Market Newswire · 2026/7/31
  • Rating change
    Analysts' Opinions Are Mixed on These Healthcare Stocks: Vericel (VCEL), Sarepta Therapeutics (SRPT) and Neumora Therapeutics, Inc. (NMRA)
    TipRanks · 2026/7/28
  • Rating change
    H.C. Wainwright Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $70
    Market Newswire · 2026/5/8
  • H.C. Wainwright Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $75
    Market Newswire · 2026/11/6
  • Rating change
    H.C. Wainwright Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $72
    Market Newswire · 2026/7/31
  • Truist Financial Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $65
    Market Newswire · 2026/11/7
  • Rating change
    Truist Financial Maintains Vericel(VCEL.US) With Buy Rating, Announces Target Price $52
    Market Newswire · 2026/10/14
  • Rating change
    TD Cowen Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $58
    Market Newswire · 2026/9/4
  • Stephens Initiates Vericel(VCEL.US) With Buy Rating, Announces Target Price $68
    Market Newswire · 2026/11/10
  • Rating change
    CCORF Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $58
    Market Newswire · 2026/6/25
  • Rating change
    Truist Financial Maintains Vericel(VCEL.US) With Buy Rating
    Market Newswire · 2026/8/20
  • Rating change
    H.C. Wainwright Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $64
    Market Newswire · 2026/2/28
  • Rating change
    H.C. Wainwright Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $72
    Market Newswire · 2026/11/4
  • TD Cowen Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $63
    Market Newswire · 2026/11/6
  • Rating change
    TD Cowen Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $55
    Market Newswire · 2026/7/29
  • Rating change
    H.C. Wainwright Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $70
    Market Newswire · 2026/7/28
  • BTIG Maintains Vericel(VCEL.US) With Hold Rating
    Market Newswire · 2026/11/6
  • Rating change
    Truist Financial Maintains Vericel(VCEL.US) With Buy Rating, Cuts Target Price to $42
    Market Newswire · 2026/4/15
  • Rating change
    Ladenburg Thalmann & Co. Sticks to Their Buy Rating for Vericel (VCEL)
    TipRanks · 2026/2/27
  • Rating change
    H.C. Wainwright Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $60
    Market Newswire · 2026/1/20
  • Rating change
    Truist Financial Maintains Vericel(VCEL.US) With Buy Rating, Announces Target Price $48
    Market Newswire · 2026/2/27
  • Rating change
    Truist Financial Maintains Vericel(VCEL.US) With Buy Rating, Cuts Target Price to $45
    Market Newswire · 2025/12/18
  • Rating change
    Analysts Have Conflicting Sentiments on These Healthcare Companies: BrightSpring Health Services, Inc. (BTSG), Medtronic (MDT) and Vericel (VCEL)
    TipRanks · 2025/11/20

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Vericel discussion 0 comments

Add a comment